First published 9/28/2026, 3:16:15 AM · Last updated 9/28/2026, 3:16:15 AM

Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002)

Journal article published 2026-01-01 comparing primary chemoradiation and radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement. The supplied excerpt contains only publisher and content-type metadata and includes no study results or additional details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 4/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 2/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study compares treatment approaches for a specific stage of cervical cancer, which could inform clinical decisions if results are reported.

Sources

Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002)

Report an issue